课题基金 / 基金详情

Neurohormoral adverse remodeling in chronic heart failure; validation of a novel imaging approach (A) and evaluation of right heart failure targeted treatment (STAR-HF)(B)

Neurohormoral adverse remodeling in chronic heart failure; validation of a novel imaging approach (A) and evaluation of right heart failure targeted treatment (STAR-HF)(B)
慢性心力衰竭的神经激素不良重塑;
批准号:
358923
负责人:
Kandolin Riina
金额:
$10.2万
依托单位国家:
加拿大
项目类别:
Fellowship Programs
财政年份:
2016
资助国家:
加拿大
项目状态:
已结题
起止时间:
2016-09-01 至 2018-09-01

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
在加拿大,心脏病是导致疾病和死亡的主要原因,而心力衰竭是大多数心脏病的最终共同途径。即使在目前的治疗下,心力衰竭患者的数量也在增加。右心衰竭
英文摘要
Heart disease is the leading cause of illness and death in Canada and heart failure is the final common pathway for most forms of heart diseases. Even with current treatments, the numbers of patients with heart failure are increasing. Right heart failure
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金